1-2 of 2
James Forryan
Close
Sort by
Journal Articles

Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib

Clinical Trials & Observations
Alex Rampotas, Luke Carter-Brzezinski, Tim C. P. Somervaille, James Forryan, Fotios Panitsas, Claire Harrison, Ruth Witherall, Andrew J. Innes, Louise Wallis, Naumann M. Butt, Bethan Psaila, Adam J. Mead, Matthew Carter, Anna L. Godfrey, Heather Laing, Mamta Garg, Sebastian Francis, Joanne Ewing, Chun Huat Teh, Hannah Bibi Cowen, Peter Dyer, Conall McConville, Frances Wadelin, Ali Sahra, Andrew McGregor, Elizabeth Kulakov, Donal P. McLornan, Jonathan Lambert
Journal: Blood
Blood (2024) 143 (2): 178–182.
https://doi.org/10.1182/blood.2023022345
Published: 2024
Includes: Supplemental data
Journal Articles

Disease Characteristics and Outcomes of Non-Melanoma Skin Cancers in Myeloproliferative Neoplasm (MPN) Patients Treated with Ruxolitinib

Alexandros Rampotas, Luke Carter-Brzezinski, Tim C.P Somervaille, James Forryan, Bethan Psaila, Adam J Mead, Mamta Garg, Heather Laing, Louise Wallis, Nauman M Butt, Conal McConville, Ali Sahra, Andrew McGregor, Hannah Cowan, Andrew J. Innes, Joanne Ewing, Matthew Carter, Peter Dyer, Chun Huat Teh, Sebastian Francis, Frances Wadelin, Claire Harrison, Anna L Godfrey, Elizabeth Kulakov, Donal P. McLornan, Jonathan Lambert
Journal: Blood
Blood (2022) 140 (Supplement 1): 9721–9723.
https://doi.org/10.1182/blood-2022-162417
Published: 2022